Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin
References (23)
- et al.
Isomeric selectivity at dopamine D3 receptors
Eur. J. Pharmacol.
(1993) - et al.
Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cells
Mol. Cell. Endocrinol.
(1978) - et al.
Protein measurement with the folin phenol reagent
J. Biol. Chem.
(1951) - et al.
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor
Eur. J. Pharmacol.
(1992) Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain
Brain Res.
(1991)- et al.
Intraventricular injection of neurotensin reduces dopamine D-2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence
Brain Res.
(1990) - et al.
Reactive sulfhydryl groups of a39, a guanine nucleotide binding protein from brain: location and function
J. Biol. Chem.
(1987) - et al.
Neurotensin in vitro markedly reduces the affinity in subcortical limbic [3H]N-propylnorapomorphine binding sites
Acta Physiol. Scand.
(1983) - et al.
Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction
Biochem. Pharmacol.
(1973) - et al.
Model systems for the study of seven-transmembrane-segment receptors
Annu. Rev. Biochem.
(1991)
Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals
J. Neurochem.
Cited by (25)
The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: Potentiation of risperidone-, but not haloperidol-, induced dopamine efflux
2007, Brain ResearchCitation Excerpt :In support of this, application of NT into the PFC has been shown to enhance the spontaneous activity of DA neurons in the VTA (Rompre et al., 1998; Fatigati et al., 2000). Third, NT1 receptors may reduce the inhibitory influence of D2 pre- and post-synaptic receptors (Agnati et al., 1983; von Euler et al., 1989; von Euler et al., 1990; Liu et al., 1994) either through an allosteric receptor/receptor interaction involving second messengers (von Euler et al., 1991; Fuxe et al., 1992; Jomphe et al., 2006) or by direct noncompetive binding of NT to the D2 receptor (Mandell et al., 1998). In support of this, Beauregard et al. (1992) found that iontophoretic application of DA and NT into the PFC and NAC in urethane-anesthetized rats decreased the inhibitory effects of DA in 74% of the PFC and 48% of the NAC neurons tested.
Pharmacology of [<sup>3</sup>H]R(+)-7-OH-DPAT binding in the rat caudate-putamen
2001, Neurochemistry InternationalInvolvement of dopamine receptors in the antipsychotic profile of(-)eticlopride
1997, Physiology and Behavior
This work was supported by a grant from the Swedish Medical Research Council (14X-10377-01).